1-3 of 3
Yajuan Cui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results of a Retrospective Study on a Regimen Based on Orelabrutinib Combined with Anti-CD20 Monoclonal Antibody in Patients with Marginal Zone Lymphoma

Hongling Peng, Xixi Xiang, Jun Rao, Wenzhe Yan, Yajuan Cui, Ji Li, Yafeng Jiang, Xi Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6293.
https://doi.org/10.1182/blood-2024-203787
Published: 2024
Journal Articles

A Phase 2 Clinical Trial of Anti-CD19 CAR-T (pCAR-19B) in Chinese Pediatric and Young Adult with Relapsed/Refractory (R/R) CD19+ B-ALL: The First Pivotal Study in an Asian Population

Ruidong Zhang, Yang Cao, Xiaofan Zhu, Zhenya Hong, Jianwen Xiao, Fei Li, Ju Gao, Hongling Peng, Yongmin Tang, Runming Jin, Sixi Liu, Yajuan Cui, Shaoyan Hu, Min Yu, Xiaojun Xu, Xiaoyan Wu, Xiaoxi Lu, Huirong Mai, Xiaoxi Zhou, Yingzi Zhang, Zhi Yang, Yufeng Huang, Xiao He, Liang Huang, Cheng Qian, Yicheng Zhang, Tianyou Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4205.
https://doi.org/10.1182/blood-2024-206408
Published: 2024
Journal Articles

Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations

Yajuan Cui, Master, Bing Li, Robert Peter Gale, MD PhD DSc, FACP, Qian Jiang, Zefeng Xu, MD, Tiejun Qin, Peihong Zhang, Yue Zhang, Zhijian Xiao, MD
Journal: Blood
Blood (2014) 124 (21): 5578.
https://doi.org/10.1182/blood.V124.21.5578.5578
Published: 2014